Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Amortizatization of Intangibles: 2022-2025

Historic Amortizatization of Intangibles for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $1.6 million.

  • Gossamer Bio's Amortizatization of Intangibles fell 56.67% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.6 million, marking a year-over-year decrease of 28.01%. This contributed to the annual value of $13.1 million for FY2024, which is 38.22% up from last year.
  • Latest data reveals that Gossamer Bio reported Amortizatization of Intangibles of $1.6 million as of Q3 2025, which was down 18.47% from $1.9 million recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Amortizatization of Intangibles ranged from a high of $3.7 million in Q3 2024 and a low of $639,000 during Q2 2022.
  • For the 3-year period, Gossamer Bio's Amortizatization of Intangibles averaged around $2.6 million, with its median value being $2.8 million (2023).
  • In the last 5 years, Gossamer Bio's Amortizatization of Intangibles spiked by 440.27% in 2023 and then slumped by 56.67% in 2025.
  • Quarterly analysis of 4 years shows Gossamer Bio's Amortizatization of Intangibles stood at $663,000 in 2022, then skyrocketed by 440.27% to $3.6 million in 2023, then fell by 6.09% to $3.4 million in 2024, then tumbled by 56.67% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q3 2025, $1.9 million for Q2 2025, and $2.7 million during Q1 2025.